ZMT Zurich MedTech AG is a Swiss-based startup that focuses on developing and providing innovative software solutions for targeted life science applications. The company's premier simulation platform, Sim4Life, integrates powerful multi-physics technology with advanced functionalized computable human and animal phantoms, and versatile tissue models. This allows for the assessment of physiological responses through advanced solvers and tissue models for various aspects such as electromagnetics, thermal, acoustic, flow perfusion, neuronal dynamics, and tissue-damage models. Additionally, ZMT offers fully characterized and ISO17025-calibrated measurement systems for model generation, verification, and validation of in silico based evaluations. The systems are designed to be user-friendly and seamlessly integrated with Sim4Life. Notably, ZMT is part of the Zurich43 alliance, collaborating with partner organizations including the Foundation for Research on Information Technologies in Society (IT’IS), Schmid & Partner Engineering AG (SPEAG), and TI Solutions AG (TI Solutions). The startup's slogan "In Silico We Trust" encapsulates its commitment to advancing in silico technologies for the benefit of the medical and life sciences industries. Overall, ZMT Zurich MedTech AG presents a compelling proposition, leveraging cutting-edge simulation technology and strategic partnerships to address the evolving needs of the life science sector.
There is no investment information
No recent news or press coverage available for ZMT Zurich MedTech AG.